publity AG

  • WKN: 697250
  • ISIN: DE0006972508
  • Land: Deutschland

Nachricht vom 30.08.2019 | 14:09

publity AG: The contract regarding the contribution of up to 94.9% of publity Investor GmbH to PREOS Real Estate AG in return for the issue of new shares has been concluded

DGAP-News: publity AG / Key word(s): Contract/Miscellaneous

30.08.2019 / 14:09
The issuer is solely responsible for the content of this announcement.


Press Release

The contract regarding the contribution of up to 94.9% of publity Investor GmbH to PREOS Real Estate AG in return for the issue of new shares has been concluded

Frankfurt/Main, 30 August 2019 - The contribution agreement of up to 94.9% of the share capital of publity Investor GmbH ("Investor"), a wholly owned subsidiary of publity, into PREOS Real Estate AG ("PREOS") has been concluded on 29 August 2019.
At the company's Annual Shareholders' Meeting, the shareholders of PREOS resolved to acquire up to 94.9% of publity Investor GmbH ("Investor") in exchange for new shares as part of a non-cash capital increase. The resolution was passed with a majority of 99.96 percent of the votes. The acquisition will be implemented by issuing new PREOS shares as part of a non-cash capital increase, excluding shareholders' subscription rights.
The Investor is a 100% subsidiary of publity AG ("publity"). The non-cash capital increase will be carried out by granting up to 47,450,000 new shares at a value of EUR 8.00 per share to publity. The exchange ratio is 5:2, i.e. for every two shares in the Investor, publity will receive five new shares in PREOS. The exchange ratio is based on an evaluation of the Investor of approx. EUR 400 million. The capital increase is to be implemented to the maximum possible extent, at which the percentage share of the shares to be contributed to the Investor is still below the participation threshold applicable at that time, above which the contribution would trigger the payment of real estate transfer tax.

Press Contact:

Finanzpresse und Investor Relations:
edicto GmbH
Axel Mühlhaus/ Peggy Kropmanns
Phone: +49 69 905505-52
Mail: publity@edicto.de

About publity

publity AG ("publity") is an asset manager and investor specialised in office real estate in Germany. The company covers the core of the value chain from the acquisition to the development and the sale of real estate. With over 1,100 transactions in the past seven years, publity is one of the most active players in the real estate market. Currently, the company manages a portfolio with a value of over five billion euros. publity is characterized by a sustainable network in the real estate industry and in the Work-Out departments of financial institutions. With very good access to investment funds, publity handles transactions rapidly with a highly efficient process and proven partners. On a case-by-case basis, publity participates as co-investor in joint venture transactions to a limited extent. The shares of publity AG (ISIN DE0006972508) are traded on the Scale segment of Deutsche Börse.

 



30.08.2019 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

Anleihe im Fokus

Deutsche Rohstoff
"Anleihe - Jetzt zeichnen!"

- Emissionsvolumen: bis zu 100 Mio. EUR
- Zeichnungsfrist: 11.11. bis 04.12.2019
- ISIN: DE000A2YN3Q8 / WKN: A2YN3Q
- Börsenesegment: Börse Frankfurt, Open Market (Quotation Board)
- Stückelung / Emissionspreis: 1.000 EUR/ 100%
- Zinssatz (Kupon): 5,25 %
- Laufzeit: 5 Jahre
- Fälligkeit: 5 Jahre / 6.12.2024 (vorbehaltliche vorzeitige Rückzahlung gemäß Anleihebedingungen)
- Zinszahlung: Angebot an Inhaber der 5,625 % Schuldverschreibung 2016/2021 (WKN A2AA05, ISIN DE000A2AA055) diese in die neue Anleihe zu tauschen
- Umtauschfrist: 11.11.2019 – 29.11.2019 (18.00 Uhr)

GBC-Fokusbox

Expedeon AG mit attraktiver Produktpipeline

Durch die konsequente Fortsetzung der „Grow, Buy & Build“-Strategie hat die im Bereich der Entwicklung und Vermarktung von DNA-Technologien, Proteomik- und Antikörper-Konjugations-Anwendungen tätige Expedeon AG das Umsatzniveau angehoben und auf operativer Ergebnisebene zugleich den Break-Even nachhaltig überschritten. Für die kommenden Perioden ist der Ausbau der Umsatzerlöse mit den bestehenden Produkten geplant. Darüber hinaus verfügt die Expedeon AG über eine attraktive Produktpipeline mit hohem Umsatzpotenzial. Unser Kursziel liegt bei 3,20 € je Aktie. Das Rating lautet KAUFEN.

News im Fokus

Henkel AG & Co. KGaA: Henkel bestätigt Ausblick für das Geschäftsjahr 2019

14. November 2019, 07:30

Aktueller Webcast

EQS Group AG

Conference Call zu den Neunmonatszahlen 2019

15. November 2019

Aktuelle Research-Studie

SMT Scharf AG

Original-Research: SMT Scharf AG (von Montega AG): Kaufen

14. November 2019